Mirion (MIR) announced three new leadership appointments. Tighe Smith has been promoted to the newly created role of chief nuclear officer to lead the company’s global nuclear strategy. Shelia Webb transitions to president, Nuclear Medicine, focusing on strategic development in that market. Additionally, Shahmeer Mirza has been appointed as the company’s inaugural chief artificial intelligence and digital officer.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MIR:
- Mirion: Strong Profitability, Backlog Growth, and 2026 Outlook Support Buy Rating and Upside Potential
- Mirion reports Q4 adjusted EPS 15c, consensus 16c
- Mirion sees FY26 adjusted EPS 50c-57c, consensus 61c
- MIR Upcoming Earnings Report: What to Expect?
- Mirion initiated with an Equal Weight at Morgan Stanley